Quarter Period Consolidated Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7724353

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Quarter period consolidated statement of income
Statement of income
Net sales
98,430,000,000 JPY
2,407,000,000 JPY
96,022,000,000 JPY
96,891,000,000 JPY
98,430,000,000 JPY
JPY
99,949,000,000 JPY
JPY
2,386,000,000 JPY
99,093,000,000 JPY
101,479,000,000 JPY
101,479,000,000 JPY
Cost of sales
41,114,000,000 JPY
42,405,000,000 JPY
43,275,000,000 JPY
44,539,000,000 JPY
Gross profit (loss)
55,777,000,000 JPY
56,024,000,000 JPY
56,673,000,000 JPY
56,940,000,000 JPY
Selling, general and administrative expenses
Salaries
7,106,000,000 JPY
7,152,000,000 JPY
7,233,000,000 JPY
7,274,000,000 JPY
Depreciation
203,000,000 JPY
204,000,000 JPY
274,000,000 JPY
275,000,000 JPY
Selling, general and administrative expenses
28,391,000,000 JPY
28,530,000,000 JPY
26,597,000,000 JPY
26,745,000,000 JPY
Operating profit (loss)
27,496,000,000 JPY
1,655,000,000 JPY
25,840,000,000 JPY
27,388,000,000 JPY
27,496,000,000 JPY
JPY
30,588,000,000 JPY
JPY
1,629,000,000 JPY
29,078,000,000 JPY
30,707,000,000 JPY
30,707,000,000 JPY
Non-operating income
Interest income
5,000,000 JPY
4,000,000 JPY
Dividend income
304,000,000 JPY
278,000,000 JPY
Non-operating income
412,000,000 JPY
412,000,000 JPY
343,000,000 JPY
343,000,000 JPY
Non-operating expenses
Interest expenses
16,000,000 JPY
16,000,000 JPY
21,000,000 JPY
21,000,000 JPY
Non-operating expenses
53,000,000 JPY
53,000,000 JPY
69,000,000 JPY
69,000,000 JPY
Ordinary profit (loss)
27,747,000,000 JPY
27,854,000,000 JPY
30,863,000,000 JPY
30,981,000,000 JPY
Extraordinary income
Extraordinary income
JPY
JPY
253,000,000 JPY
252,000,000 JPY
Extraordinary losses
Extraordinary losses
165,000,000 JPY
168,000,000 JPY
142,000,000 JPY
142,000,000 JPY
Profit (loss) before income taxes
27,581,000,000 JPY
27,686,000,000 JPY
30,973,000,000 JPY
31,092,000,000 JPY
Income taxes - current
9,170,000,000 JPY
9,206,000,000 JPY
8,108,000,000 JPY
8,147,000,000 JPY
Income taxes - deferred
-563,000,000 JPY
-563,000,000 JPY
924,000,000 JPY
928,000,000 JPY
Income taxes
8,607,000,000 JPY
8,643,000,000 JPY
9,032,000,000 JPY
9,075,000,000 JPY
Profit (loss)
18,974,000,000 JPY
18,974,000,000 JPY
18,974,000,000 JPY
19,043,000,000 JPY
18,974,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY
22,017,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
19,043,000,000 JPY
19,043,000,000 JPY
19,043,000,000 JPY
22,017,000,000 JPY
22,017,000,000 JPY
22,017,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
898,000,000 JPY
187,000,000 JPY
Remeasurements of defined benefit plans, net of tax
811,000,000 JPY
382,000,000 JPY
Other comprehensive income
1,710,000,000 JPY
570,000,000 JPY
Comprehensive income
20,753,000,000 JPY
22,587,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
20,753,000,000 JPY
22,587,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.